Hand Sanitizer (Pharmacies) - New Zealand

New Zealand

Highlights

Revenue in the Hand Sanitizer market is projected to reach US$1.46m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.79%, resulting in a market volume of US$1.68m by 2029.
In global comparison, most revenue will be generated China (US$385.20m in 2024).
In relation to total population figures, per person revenues of US$0.28 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Hand Sanitizer (Pharmacies) market in New Zealand has been experiencing significant growth in recent years.

Customer preferences: Customers in New Zealand have shown a strong preference for hand sanitizers purchased from pharmacies. This is due to the trust and reliability associated with these establishments, as well as the convenience of being able to purchase hand sanitizers along with other healthcare products. Additionally, pharmacies often stock a wide range of hand sanitizers, catering to different customer preferences such as scent, size, and ingredients.

Trends in the market: One of the key trends in the Hand Sanitizer (Pharmacies) market in New Zealand is the increasing demand for natural and organic hand sanitizers. Customers are becoming more conscious about the ingredients used in their personal care products and are opting for products that are free from harmful chemicals. As a result, pharmacies are expanding their range of natural and organic hand sanitizers to meet this growing demand. Another trend in the market is the rise in demand for travel-sized hand sanitizers. With the increasing popularity of travel and the need for hygiene while on the go, customers are looking for portable and convenient hand sanitizers that can easily fit in their bags or pockets. Pharmacies are capitalizing on this trend by offering a variety of travel-sized hand sanitizers, catering to the needs of frequent travelers and those who are always on the move.

Local special circumstances: New Zealand has a unique geographical location, being an island nation in the southwestern Pacific Ocean. This has led to strict border control measures and a strong focus on biosecurity. The country has a history of successfully managing outbreaks and preventing the introduction of invasive species. As a result, there is a heightened awareness and emphasis on hygiene practices, including the use of hand sanitizers. This local special circumstance has contributed to the growth of the Hand Sanitizer (Pharmacies) market in New Zealand.

Underlying macroeconomic factors: The COVID-19 pandemic has had a significant impact on the Hand Sanitizer (Pharmacies) market in New Zealand. The outbreak of the virus has led to increased awareness about the importance of hand hygiene, resulting in a surge in demand for hand sanitizers. Pharmacies have been at the forefront of meeting this demand, as they are considered essential businesses and have remained open throughout the pandemic. The government's efforts to promote hand hygiene and the availability of hand sanitizers in pharmacies have further fueled the growth of the market. In conclusion, the Hand Sanitizer (Pharmacies) market in New Zealand is experiencing growth due to customer preferences for pharmacy-purchased products, trends such as the demand for natural and travel-sized hand sanitizers, local special circumstances related to biosecurity, and the impact of the COVID-19 pandemic.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.